[HTML][HTML] Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
The concept of PLGA-lipid hybrid nanoparticles arose as a motivation for developing drug
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …
[HTML][HTML] Bile acids activated receptors regulate innate immunity
Once known exclusively for their role in nutrients absorption, primary bile acids,
chenodeoxycholic and cholic acid, and secondary bile acids, deoxycholic and lithocholic …
chenodeoxycholic and cholic acid, and secondary bile acids, deoxycholic and lithocholic …
A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis
M Zhang, L Zhou, Y Xu, M Yang, Y Xu, GP Komaniecki… - Nature, 2020 - nature.com
Cysteine palmitoylation (S-palmitoylation) is a reversible post-translational modification that
is installed by the DHHC family of palmitoyltransferases and is reversed by several acyl …
is installed by the DHHC family of palmitoyltransferases and is reversed by several acyl …
[HTML][HTML] Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis
OH Nielsen, JM Gubatan, CB Juhl, SE Streett… - Clinical …, 2022 - Elsevier
Background & Aims Biologics are used routinely in pregnant women with inflammatory
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …
Emerging pharmacotherapy for inflammatory bowel diseases
H Luo, G Cao, C Luo, D Tan, CT Vong, Y Xu… - Pharmacological …, 2022 - Elsevier
Inflammatory bowel disease (IBD) refers to a gamut of disorders that are characterized by
chronic intestinal inflammation, including ulcerative colitis (UC) and Crohn's disease (CD) …
chronic intestinal inflammation, including ulcerative colitis (UC) and Crohn's disease (CD) …
Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: Focus on the available therapeutic approaches and gut microbiome
A Shahini, A Shahini - Journal of Cell Communication and Signaling, 2023 - Springer
Inflammatory bowel disease (IBD) is considered a chronic inflammatory and multifactorial
disease of the gastrointestinal tract. Crohn's disease (CD) and ulcerative colitis (UC) are two …
disease of the gastrointestinal tract. Crohn's disease (CD) and ulcerative colitis (UC) are two …
Inflammatory bowel disease: between genetics and microbiota
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease that can
involve any part of the gastrointestinal tract. It includes two main disorders: Crohn's disease …
involve any part of the gastrointestinal tract. It includes two main disorders: Crohn's disease …
[HTML][HTML] Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Janus kinase (JAK) inhibitors, also known as jakinibs, are third-generation oral small
molecules that have expanded the therapeutic options for the management of chronic …
molecules that have expanded the therapeutic options for the management of chronic …
[HTML][HTML] Emerging therapies for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic heterogeneous group of diseases that has
undergone major advances in the understanding of its etiology and pathogenesis in recent …
undergone major advances in the understanding of its etiology and pathogenesis in recent …
[HTML][HTML] Inflammatory bowel disease: a stressed “gut/feeling”
Y Oligschlaeger, T Yadati, T Houben… - Cells, 2019 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic and relapsing intestinal inflammatory
condition, hallmarked by a disturbance in the bidirectional interaction between gut and …
condition, hallmarked by a disturbance in the bidirectional interaction between gut and …